London-based researchers want to cure heart attacks with mRNA technology used in the experimental COVID-19 shots.
In related news, Duke researchers want to use mRNA technology to potentially develop a cancer vaccine.
Is the solution for every medical problem a vaccine for scientists nowadays?
Vaccine manufacturers aren’t held liable for injuries caused by shots, so it’s a lucrative profit over health model.
Thus, the ‘cure’ for every disease must be a vaccine for many scientists.
Heart attacks, cancer, etc.
Vaccines for obesity, COPD, or strokes?
At Duke University, they’re working with mRNA technology to create vaccines for cancer.
— Wittgenstein (@backtolife_2022) April 16, 2022
“For the last several years, researchers have been working with technology based around mRNA—messenger RNA, which is something that compliments the work of your DNA—to see if they can utilize it to get your body’s own immune system to fight cancers,” a FOX 8 report explains.
“It is a product which is RNA nucleic acid which encodes a specific protein and then that can be encapsulated in something we like to call a lipid nanoparticle, which is really a little fat bubble, and that can be injected into your body and sort of teaches your body what to go after immunologically,” said Zachary Hartman who works in the Lyerly Lab at Duke.
If it all sounds familiar, it should—mRNA vaccines have been in the news quite a bit over the last two years. It’s the type of technology used to create the COVID-19 vaccines.
“Remember, people were expecting that a successful vaccine would provide protective immunity to about 50% of patients, and the first two mRNA vaccines provided over 90% protection, a remarkable achievement,” said Dr. H. Kim Lyerly, the man who runs the lab at Duke.
Lyerly has been at Duke nearly 40 years and has seen massive changes in how we can combat cancer going from relatively crude chemotherapy to very targeted immunotherapy.
“Think about that: in my career, a complete reversal of fortune for immunotherapy to be something to being considered an outsider, not likely to ever work, to being the most prominent form of cancer therapy and the development of new cancer therapeutics in the world, today,” said Dr. Lyerly.
Of course, Dr. Lyerly’s response to mRNA vaccine skepticism is the typical arrogant scientist attitude.
“You have mRNAs – billions of mRNA copies in your body, right now. And so, to be concerned that the introduction of an mRNA coding of a viral protein is going to be harmful to you, again, doesn’t make a lot of sense to me, because if you happen to be infected with a coronavirus, you’re going to have a thousand times more mRNAs from the virus invading your body. So, the way to protect yourself from disease-causing mRNAs in your body is to vaccinate yourself,” he said.
Fox News added:
So in 2019, the Duke researchers found potential in a phase 1 clinical trial with a vaccine that induced anti-tumor growth in seven of the 22 patients who had recurrent breast cancer, with two continuing to survive at the time of the published research, according to an updated July 9, 2019 press release.
He told Fox News, “We have been working on this [vaccine mRNA] technology for many years. The COVID-19 pandemic highlighted the potency of the approach.”
Although the current vaccine, which is a synthetic mRNA vaccine, is directed against breast cancer, it can be used for other cancers that express the HER2 protein, including lung cancer, stomach, and esophageal cancer, Lverly added.
“Vaccines stimulate the immune system, specifically killer T cells, that now are active and react to seek and destroy tumor cells. It programs the immune system to not ignore the tumor cells, but to recognize them as bad guys to kill them,” Lyerly told Fox News.
“Vaccination is the best way to protect against COVID-19,” Lyerly added.
My response to that statement is a big fat NO.
Just take a brief look at the states with the highest level of community transmission:
New York 👀
— Sarah Allen (@Mssarahmssarah) April 16, 2022
NBC Boston reported:
Two omicron subvariants of the highly transmissible BA.2 strain are fueling significant community spread in Massachusetts and the other New England states.
The emergence of subvariants BA.2.12 and BA.2.12.1, both sublineages of the BA.2 strain that some have described as the most contagious version of COVID yet, comes as that parent subvariant intensifies its already-dominant grip on America and New England, where data shows it’s circulating at a faster rate than nationally.
Centers for Disease Control and Prevention data puts BA.2’s prevalence at over 90% of cases in New England. And early findings indicate the subvariants could be up to 27% higher than BA.2, which was said to be up to 60% more contagious than the original omicron strain that overtook the globe, leading to unprecedented case rates earlier this year.
The Northeast has been hit hardest so far — with more than 90% of new infections caused by BA.2 last week compared with 86% nationally. As of Thursday, the highest rates of new COVID cases per capita over the past 14 days were in Vermont, Rhode Island, Alaska, New York and Massachusetts.
U.S. News stated:
Massachusetts, Rhode Island and Connecticut have partially vaccinated at least 95% of their populations, which is where the CDC caps off reporting.
These are the states with the highest partial vaccination rates:
1. (tie) Massachusetts (95%)
1. (tie) Rhode Island (95%)
1. (tie) Connecticut (95%)
4. Vermont (93.2%)
5. New Hampshire (90.6%)
6. New Jersey (90%)
7. Maine (89.9%)
8. New York (89.8%)
9. (tie) Hawaii (87.1%)
9. (tie) New Mexico (87.1%)
Lyerly also disclosed to Fox News that he has equity in AlphaVax, a biopharmaceutical company that has patents on mRNA vaccines.
So, it’s good to know future mRNA vaccines will enrich the doctor’s pockets.